Pharmaceutical Services

We offer biopharmaceutical services tailored to suit your R&D projects as well as face your solubility challenges with your API.

Marinomed Biotech AG offers a wide range of cell based toxicological, immunological or antiviral assays to interrogate the biological activity, toxicity or mechanism of action of a test molecule via our Solv4U services and partnerships program.

Furthermore, we have implemented several in-vitro and ex-vivo decongestion, moisturizing, barrier and permeation assays in order to evaluate potential efficacy of your API or novel formulation. These assays might be your first indication, or comparison to a reference or marketed product, about a potential success of your R&D project at very early stage. 

Cyto-tox

  • Various cell lines from various species and organs, e.g. Vero, L929, HCE-S,… or primary cells (PBMC, BMMC)

Hemolysis

  • On red blood cells

T-cells

  • Jurkat cell lines, primary human cells/stimuli PMA-Iono/CD3-CD28 pathways/different cytokines

Dendritic cells

  • Cell line DC18C10/stimuli PMA-Iono, LPS/NF-kB pathway/TNF-alpha and other cytokines

Mast cells

  • CFTL-12, primary mouse cells/stimuli PMA-Iono, IgE-AG/calcineurin inhibitors (or clobetasol) for TNF-alpha, histamine release, other cytokines and chemokines

Hemagglutination inhibition

  • Influenza A viruses endemic and pandemic (e.g., H1N1, H3N2, H7N7) 
  • Influenza B virus (e.g., Yamagata)
  • Human Coronavirus OC43
  • Human Parainfluenzavirus 3 

Infectivity assay (single round)

  • SARS-CoV-2 Lentivirus pseudovirus (Wuhan and variants of concern)

Replication inhibition assay

  • Influenza virus A H1N1n, H3N2, H5N1, H7N7
  • Human Rhinovirus major and minor group
  • Coxsackie A10 + A24
  • Herpes simplex virus 1 +2

Neuraminidase inhibition

  • Various influenza viruses (RBC or biochemically)

FACS-analysis

  • Cell size determination

Cell assays

  • Product relevant cells and cell lines, e.g. HCE-S, A549…

Ex-vivo

  • Porcine eye – cornea
  • Porcine nasal mucosa

In-vitro

  • For allergens, particles

In-vitro

  • PAMPA (cell-free system)

Ex-vivo

  • Porcine eyes (cornea, conjunctiva, aqueous humor, sclera, vitreous, retina,…)
  • Porcine nasal mucosa (cavity, septum)
  • Porcine stomach (fundus, corpus)
  • Porcine oral cavity (lingual, buccal mucosa)

Formulation

  • Solubility studies
  • Formulation development
  • Primary packaging compatibility

Physico-chemical parameters

  • Appearance (clarity and color), pH, conductivity

HPLC analytics

  • RP-HPLC various detection methods (CAD, DAD, UV/Vis, RI, fluorescence)
  • Method development
  • Forced degradation studies

Stability studies

  • 25°C/60%RH
  • 30°C/75%RH
  • 40°C/75%RH
Dr. Cornelia Siegl
Head Solv4U
Marinomed Biotech AG
Hovengasse 25
2100 Korneuburg, Austria
+43 2262 90300
office@marinomed.com